pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›pilocarpine
drug · small molecule
save

pilocarpine

Phase 2updated 3mo ago
by $GKOS GLAUKOS Corp🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 4
  • tagApproval2 co-mentions · 1 sources
  • companyFDC Ltd1 co-mentions · 1 sources
  • drugGLK-3021 co-mentions · 1 sources
  • drugPILOCARPINE HYDROCHLORIDE1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 4 investigational indications.

targets

Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3

all catalysts(0)

nothing on the calendar yet

Trials studying pilocarpine

  • phase3Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopiacompletedn=333
  • phase2Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopiacompletedn=150
  • EP1Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopiacompletedn=55
  • phase3Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopianot yet recruitingn=330
  • phase4Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)completedn=30
  • phase3Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adultscompletedn=145
  • phase2Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopiacompletedn=123
  • phase2Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Diseasecompletedn=226
more trials →

News(0)

no news has mentioned this drug yet

trade names
Ocusert pilo, Ocusert pilo-20, Ocusert pilo-40
generic
pilocarpine
MOA
Muscarinic acetylcholine receptor M1 agonist; Muscarinic acetylcholine receptor M3 agonist
indication
Keratoconjunctivitis Sicca (Dry Eye)
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 54m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?